{"transactions":[{"id":947446,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":70074,"kind":"person","name":"Meyers Steve Lawrence","position":1,"cik":"0002073994","reported_name":"Meyers Steve Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T16:06:48.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":197650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the reporting person's continued service to the Corporation, the shares underlying this option vest over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant."}],"balance_after":197650,"derivative":{"exercise_price":11.82,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":197650},"source":{"system":"sec-edgar","filing":"0001104659-26-001295","document":"tm261962-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2073994/000110465926001295/tm261962-7_4seq1.xml","form_type":"4"}},{"id":947445,"issuer":{"id":273,"kind":"organization","name":"OCULAR THERAPEUTIX, INC","symbol":"OCUL"},"owners":[{"id":70074,"kind":"person","name":"Meyers Steve Lawrence","position":1,"cik":"0002073994","reported_name":"Meyers Steve Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-01-06T16:06:48.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":64900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 2, 2026, the reporting person was granted restricted stock units (\"RSUs\") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the \"Corporation\"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter."}],"balance_after":217628,"source":{"system":"sec-edgar","filing":"0001104659-26-001295","document":"tm261962-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2073994/000110465926001295/tm261962-7_4seq1.xml","form_type":"4"}}]}